EU court to clarify rules on abbreviations

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EU court to clarify rules on abbreviations

IP owners whose trade marks include abbreviations will be advised whether they can be registered in Europe this week

The Court of Justice of the EU is due to rule on Thursday in two joined cases referred to it by Germany’s Federal Patent Court.

In Strigl and Securvita, the Court will decide how national courts should interpret Article 3(1)(b) and (c) of the Trade Marks directive. Article 3(1)(b) says that a trade mark cannot be registered if it is devoid of distinctive character. Article 3(1)(c) says that a mark cannot be registered it if consists exclusively of a sign or indication that designates certain characteristics of the good or service, such as its quality or intended purpose.

These cases deal with the registerability of Multi Markets Fund MMF and NAI – Der Natur-Aktien-index. Each mark is composed of a descriptive phrase and an abbreviation that is not descriptive in itself that corresponds to the first letters of the other words.

In January, Advocate General Niilo Jääskinen issued his opinion in the joined cases, in which he said that such marks must be assessed under Article 3(1)(b) of the directive, and not under Article 3(1)(c), since the marks are not composed exclusively of descriptive signs or indications.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article